Skip to main content
. 2023 Oct 6;38:101799. doi: 10.1016/j.tranon.2023.101799

Table 2.

Leukocyte count in metastatic melanoma patients during therapy.

Leukocytes (x 109/L) Baseline After IV After VIII After XII After XVI
Non-DP 8.32 ± 4.12* 7.75 ± 4.60 7.78 ± 2.99 7.66 ± 3.22 7.45 ± 3.21
DP 8.97 ± 4.74 8.72 ± 3.35 9.09 ± 4.45 8.93 ± 3.74 9.02 ± 5.09

Results are presented as mean ± standard deviation.